Injections: Is This Bump Under the Skin Normal?

March 2012
Diabetes Forecast;Mar2012, Vol. 65 Issue 3, p14
The article provides an answer to a question regarding a painless bump underneath the skin after insulin injection.


Related Articles

  • CONSULTATION STAT. Garofano, Catherine D.; Wingate, Naomi; Alberigi, Lois A.; Daybell, Judy // RN;Jun81, Vol. 44 Issue 6, p109 

    Addresses questions related to medicine. Reason why insulin reactions cause a positive Acetest reagent; Necessity of putting patients with intravenous injections on intake and output measurements; Prevention of leaks after irrigating a Salem pump through an air vent.

  • injection site rotation.  // Taber's Cyclopedic Medical Dictionary (2009);2009, Issue 21, p1200 

    An encyclopedia entry of the medical term "injection site rotation" is presented, which refers to the introduction of parenteral drugs like insulin into a different part of the body every day to prevent local tissue trauma, atrophy or lipodystrophies.

  • Catitude. Taylor, B. J. // Guideposts;Feb2008, Vol. 62 Issue 12, p69 

    A personal narrative is presented which explores the author's experience of injecting insulin to her cat that is suffering from diabetes.

  • ERRATA.  // Diabetes;Mar2010, Vol. 59 Issue 3, p756 

    Several corrections to articles that were published in previous issues are presented including "Insulin Causes Hyperthermia by Direct Inhibition of Warm-Sensitive Neurons" in a 2010 issue, "Munc18c Depletion Selectively Impairs the Sustained Phase of Insulin Release" in a 2009 issue and...

  • Time-Action Profile of the Long-Acting Insulin Analog Insulin Glargine (HOE901) in Comparison With Those of NPH Insulin and Placebo. Heinemann, Lutz; Linkeschova, Renata; Rave, Klaus; Hompesch, Beate; Sedlak, Martin; Heise, Tim // Diabetes Care;May2000, Vol. 23 Issue 5, p644 

    Presents information on a study which investigated the pharmacodynamic properties of the subcutaneously injected long-acting insulin analog HOE901 in comparison with those of NPH insulin and placebo. Research design and methods; Results; Conclusions.

  • Improved pharmacokinetic and pharmacodynamic profile of rapid- acting insulin using needle-free jet injection technology.  // Current Medical Literature: Diabetes;2011, Vol. 28 Issue 4, p138 

    The article presents a study on the difference between the subcutaneous distribution of insulin from a jet injection, Insujet, and a needle-based system where it was shown that a higher absorption rate and a more rapid onset of analogue insulin may be achieved through devices such as Insujet.

  • Insulin-induced lipoatrophy: evidence for an immune pathogenesis. Reeves, W.G.; Allen, B.R.; Tattersall, R.B. // British Medical Journal;6/21/1980, Vol. 280 Issue 6230, p1500 

    Examines the occurrence of lipoatrophy at injection sites of insulin-dependent diabetic patients. Usage of immunofluorescence for the deposition of the immunological components; Role of immunological factors in the pathogenesis of lipoatrophy; Observation of abnormal deposition of immunological...

  • INSULIN ADMINISTRATION.  // Monthly Prescribing Reference;Aug2012, Vol. 28 Issue 8, p87 

    A chart is presented which shows the administration of various insulin preparation such as insulin aspart, insulin injection regular, and insulin detemir.

  • INSULINS.  // Monthly Prescribing Reference;Aug2012, Vol. 28 Issue 8, p93 

    A chart is presented which shows various insulin preparation according to their derivation, onset, peak, and duration of action such as insulin aspart, insulin detemir, and insulin lispro.

  • insulin aspart.  // Royal Society of Medicine: Medicines;2002, p305 

    The article presents information on insulin aspart, a recombinant biosynthetic human insulin analogue, which is used in diabetic treatment to maintain diabetic patients. Insulin aspart has a faster rate of onset and offset of action than soluble insulin. Administration is by injection.


Read the Article


Sign out of this library

Other Topics